• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABCC1 和 ABCC4 在乳腺癌细胞系增殖和迁移中的作用。

Roles of ABCC1 and ABCC4 in Proliferation and Migration of Breast Cancer Cell Lines.

机构信息

College of Health & Life Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, UK.

出版信息

Int J Mol Sci. 2020 Oct 16;21(20):7664. doi: 10.3390/ijms21207664.

DOI:10.3390/ijms21207664
PMID:33081264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7589126/
Abstract

ABCC1 and ABCC4 utilize energy from ATP hydrolysis to transport many different molecules, including drugs, out of the cell and, as such, have been implicated in causing drug resistance. However recently, because of their ability to transport signaling molecules and inflammatory mediators, it has been proposed that ABCC1 and ABCC4 may play a role in the hallmarks of cancer development and progression, independent of their drug efflux capabilities. Breast cancer is the most common cancer affecting women. In this study, the aim was to investigate whether ABCC1 or ABCC4 play a role in the proliferation or migration of breast cancer cell lines MCF-7 (luminal-type, receptor-positive) and MDA-MB-231 (basal-type, triple-negative). The effects of small molecule inhibitors or siRNA-mediated knockdown of ABCC1 or ABCCC4 were measured. Colony formation assays were used to assess the clonogenic capacity, MTT assays to measure the proliferation, and scratch assays and Transwell assays to monitor the cellular migration. The results showed a role for ABCC1 in cellular proliferation, whilst ABCC4 appeared to be more important for cellular migration. ELISA studies implicated cAMP and/or sphingosine-1-phosphate efflux in the mechanism by which these transporters mediate their effects. However, this needs to be investigated further, as it is key to understand the mechanisms before they can be considered as targets for treatment.

摘要

ABCC1 和 ABCC4 利用 ATP 水解产生的能量将许多不同的分子,包括药物,从细胞内排出,因此它们与药物耐药性的产生有关。然而,最近由于它们能够转运信号分子和炎症介质,有人提出 ABCC1 和 ABCC4 可能在癌症发展和进展的标志性特征中发挥作用,而与它们的药物外排能力无关。乳腺癌是最常见的女性癌症。在这项研究中,目的是研究 ABCC1 或 ABCC4 是否在乳腺癌细胞系 MCF-7(腔型,受体阳性)和 MDA-MB-231(基底型,三阴性)的增殖或迁移中发挥作用。测量了小分子抑制剂或 siRNA 介导的 ABCC1 或 ABCCC4 敲低的效果。集落形成实验用于评估集落形成能力,MTT 实验用于测量增殖,划痕实验和 Transwell 实验用于监测细胞迁移。结果表明 ABCC1 在细胞增殖中起作用,而 ABCC4 似乎对细胞迁移更为重要。ELISA 研究表明,cAMP 和/或 1-磷酸鞘氨醇的外排在这些转运蛋白介导其作用的机制中起作用。然而,这需要进一步研究,因为在考虑将其作为治疗靶点之前,了解这些机制是关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/b3875ed22b02/ijms-21-07664-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/3c973b1e40dc/ijms-21-07664-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/404cc932a855/ijms-21-07664-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/12ff2cbed714/ijms-21-07664-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/9a26173cd319/ijms-21-07664-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/99f3f17bb433/ijms-21-07664-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/ca28c10d25ec/ijms-21-07664-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/6813b51664e7/ijms-21-07664-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/b3875ed22b02/ijms-21-07664-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/3c973b1e40dc/ijms-21-07664-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/404cc932a855/ijms-21-07664-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/12ff2cbed714/ijms-21-07664-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/9a26173cd319/ijms-21-07664-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/99f3f17bb433/ijms-21-07664-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/ca28c10d25ec/ijms-21-07664-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/6813b51664e7/ijms-21-07664-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/7589126/b3875ed22b02/ijms-21-07664-g008.jpg

相似文献

1
Roles of ABCC1 and ABCC4 in Proliferation and Migration of Breast Cancer Cell Lines.ABCC1 和 ABCC4 在乳腺癌细胞系增殖和迁移中的作用。
Int J Mol Sci. 2020 Oct 16;21(20):7664. doi: 10.3390/ijms21207664.
2
ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer.ABCC1 输出的鞘氨醇-1-磷酸由鞘氨醇激酶 1 产生,缩短了乳腺癌小鼠和患者的生存时间。
Mol Cancer Res. 2018 Jun;16(6):1059-1070. doi: 10.1158/1541-7786.MCR-17-0353. Epub 2018 Mar 9.
3
ABC transporters and neuroblastoma.ABC 转运蛋白与神经母细胞瘤。
Adv Cancer Res. 2015;125:139-70. doi: 10.1016/bs.acr.2014.10.005. Epub 2015 Jan 8.
4
Tryptophan hydroxylase 1 and 5-HT receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling.色氨酸羟化酶1和5-羟色胺受体在三阴性乳腺癌中优先表达,通过自分泌5-羟色胺信号促进癌症进展。
Mol Cancer. 2016 Nov 21;15(1):75. doi: 10.1186/s12943-016-0559-6.
5
Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.三阴性乳腺癌依赖于鞘氨醇激酶 1(SphK1)/鞘氨醇-1-磷酸(S1P)/鞘氨醇 1-磷酸受体 3(S1PR3)/Notch 信号通路促进转移。
Med Sci Monit. 2018 Apr 1;24:1912-1923. doi: 10.12659/msm.905833.
6
ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.三磷酸腺苷结合盒 ABCC1 参与了大鼠子宫肌瘤 ELT3 细胞和妊娠晚期大鼠子宫平滑肌中鞘氨醇 1-磷酸的释放。
Cell Signal. 2011 Dec;23(12):1997-2004. doi: 10.1016/j.cellsig.2011.07.010. Epub 2011 Jul 22.
7
Role of ABCC1 in export of sphingosine-1-phosphate from mast cells.ABCC1在肥大细胞中鞘氨醇-1-磷酸输出中的作用。
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16394-9. doi: 10.1073/pnas.0603734103. Epub 2006 Oct 18.
8
Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.多药耐药相关蛋白4(MRP4)可输出前列腺素E2(PGE2),并促进基底样/三阴性乳腺癌的转移。
Oncotarget. 2017 Jan 24;8(4):6540-6554. doi: 10.18632/oncotarget.14145.
9
MRP4/ABCC4 expression is regulated by histamine in acute myeloid leukemia cells, determining cAMP efflux.MRP4/ABCC4 表达受组胺调控,在急性髓系白血病细胞中决定 cAMP 外排。
FEBS J. 2021 Jan;288(1):229-243. doi: 10.1111/febs.15344. Epub 2020 May 9.
10
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).高通量筛选确定Ceefourin 1和Ceefourin 2为多药耐药蛋白4(MRP4)的高选择性抑制剂。
Biochem Pharmacol. 2014 Sep 1;91(1):97-108. doi: 10.1016/j.bcp.2014.05.023. Epub 2014 Jun 25.

引用本文的文献

1
Exploring the interplay between LDHA and ABCC1 in breast cancer using computational approach.利用计算方法探索乳腺癌中LDHA与ABCC1之间的相互作用。
Discov Oncol. 2025 Aug 5;16(1):1471. doi: 10.1007/s12672-025-03354-w.
2
Network pharmacology and in silico approach to study the mechanism of quercetin against breast cancer.基于网络药理学和计算机模拟方法研究槲皮素抗乳腺癌的作用机制
In Silico Pharmacol. 2025 Feb 6;13(1):22. doi: 10.1007/s40203-025-00306-8. eCollection 2025.
3
APX2009 sensitizes hypoxic breast cancer cells to doxorubicin by increasing its accumulation and caspase-3/7-mediated apoptosis.

本文引用的文献

1
Multidrug resistance protein 4 (MRP4/ABCC4) is overexpressed in clear cell renal cell carcinoma (ccRCC) and is essential to regulate cell proliferation.多药耐药蛋白 4(MRP4/ABCC4)在透明细胞肾细胞癌(ccRCC)中过度表达,对调节细胞增殖至关重要。
Int J Biol Macromol. 2020 Oct 15;161:836-847. doi: 10.1016/j.ijbiomac.2020.06.106. Epub 2020 Jun 15.
2
ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer.ABCC4/MRP4 促进了 Myc 相关上皮性卵巢癌的侵袭性。
Int J Cancer. 2020 Oct 15;147(8):2225-2238. doi: 10.1002/ijc.33005. Epub 2020 May 8.
3
Breast cancer statistics, 2019.
APX2009通过增加阿霉素的蓄积以及半胱天冬酶-3/7介导的凋亡,使缺氧乳腺癌细胞对阿霉素敏感。
Breast Cancer Res Treat. 2025 Feb;209(3):533-540. doi: 10.1007/s10549-024-07512-6. Epub 2024 Oct 13.
4
The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects.犬尿酸的生物学和生物化学:一种具有多种生物学效应的潜在营养保健品。
Int J Mol Sci. 2024 Aug 21;25(16):9082. doi: 10.3390/ijms25169082.
5
Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker.ABCC1作为一种潜在的预后和免疫生物标志物的泛癌分析。
Transl Oncol. 2024 Mar;41:101882. doi: 10.1016/j.tranon.2024.101882. Epub 2024 Jan 29.
6
SiRNF8 Delivered by DNA Framework Nucleic Acid Effectively Sensitizes Chemotherapy in Colon Cancer.DNA 框架核酸递呈的 SirnF8 有效增强结肠癌的化疗敏感性。
Int J Nanomedicine. 2024 Jan 6;19:171-188. doi: 10.2147/IJN.S437859. eCollection 2024.
7
Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene.通过抑制 ABCC1 基因,恢复 microRNA-34a 可克服人乳腺癌细胞系中的获得性耐药和疾病进展。
Breast Cancer Res Treat. 2024 Feb;204(1):133-149. doi: 10.1007/s10549-023-07170-0. Epub 2023 Dec 7.
8
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system.纳米载体药物递送系统在克服癌症耐药性方面的最新进展。
Cancer Drug Resist. 2023 Jun 20;6(2):390-415. doi: 10.20517/cdr.2023.16. eCollection 2023.
9
The Role of Thrombomodulin in Estrogen-Receptor-Positive Breast Cancer Progression, Metastasis, and Curcumin Sensitivity.血栓调节蛋白在雌激素受体阳性乳腺癌进展、转移及姜黄素敏感性中的作用
Biomedicines. 2023 May 7;11(5):1384. doi: 10.3390/biomedicines11051384.
10
Leisure Activities, Genetic Risk, and Frailty: Evidence from the Chinese Adults Aged 80 Years or Older.休闲活动、遗传风险与衰弱:来自中国 80 岁及以上老年人的证据。
Gerontology. 2023;69(8):961-971. doi: 10.1159/000530665. Epub 2023 Apr 19.
乳腺癌统计数据,2019 年。
CA Cancer J Clin. 2019 Nov;69(6):438-451. doi: 10.3322/caac.21583. Epub 2019 Oct 2.
4
Triple-negative breast cancer: current perspective on the evolving therapeutic landscape.三阴性乳腺癌:不断演变的治疗格局的当前视角
Int J Womens Health. 2019 Jul 31;11:431-437. doi: 10.2147/IJWH.S178349. eCollection 2019.
5
Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux.鉴定 MRP4/ABCC4 为通过调节 cAMP 外排来减少胰腺导管腺癌细胞增殖的靶点。
Mol Pharmacol. 2019 Jul;96(1):13-25. doi: 10.1124/mol.118.115444. Epub 2019 May 1.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
Revisiting the role of ABC transporters in multidrug-resistant cancer.重新审视 ABC 转运蛋白在多药耐药性癌症中的作用。
Nat Rev Cancer. 2018 Jul;18(7):452-464. doi: 10.1038/s41568-018-0005-8.
8
ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer.ABCC1 输出的鞘氨醇-1-磷酸由鞘氨醇激酶 1 产生,缩短了乳腺癌小鼠和患者的生存时间。
Mol Cancer Res. 2018 Jun;16(6):1059-1070. doi: 10.1158/1541-7786.MCR-17-0353. Epub 2018 Mar 9.
9
Release of Platelet-Derived Sphingosine-1-Phosphate Involves Multidrug Resistance Protein 4 (MRP4/ABCC4) and Is Inhibited by Statins.血小板衍生的鞘氨醇-1-磷酸的释放涉及多药耐药蛋白 4(MRP4/ABCC4),并受他汀类药物抑制。
Thromb Haemost. 2018 Jan;118(1):132-142. doi: 10.1160/TH17-04-0291. Epub 2018 Jan 5.
10
Trends and predictions to 2020 in breast cancer mortality in Europe.欧洲乳腺癌死亡率的趋势和预测到 2020 年。
Breast. 2017 Dec;36:89-95. doi: 10.1016/j.breast.2017.06.003. Epub 2017 Oct 4.